Evidence map›Paper›PMID 34066812›Full record

ArticleToxins2021

Ixchel Campos-Avelar, Alexandre Colas de la Noue, Noël Durand, Guillaume Cazals, Véronique Martinez, Caroline Strub, Angélique Fontana, Sabine Schorr-Galindo

Open access · goldAbstract read
In one paragraph

Article in Toxins, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Food science & nutrition · 2025
    Article
  4. Article
  5. Biocontrol of Mycotoxigenic Fungi by Actinobacteria.Journal of fungi (Basel, Switzerland) · 2024
    Review
  6. Rice Weevil (Journal of fungi (Basel, Switzerland) · 2024
    Article
  7. Article
  8. Screening and identification of an aflatoxin BFrontiers in microbiology · 2024
    Article
  9. Characterization and genomic analysis ofFrontiers in microbiology · 2024
    Article
  10. Article
  11. Effect ofToxins · 2023
    Article
  12. Article
  13. Exposure ofJournal of fungi (Basel, Switzerland) · 2023
    Article
  14. The potential of facultative predatoryFrontiers in microbiology · 2022
    Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Ixchel Campos-AvelarUMR Qualisud, University of Montpellier, 34095 Montpellier, France.ORCID 0000-0001-6889-5136
Alexandre Colas de la NoueUMR Qualisud, University of Montpellier, 34095 Montpellier, France.
Noël DurandUMR Qualisud, University of Montpellier, 34095 Montpellier, France.ORCID 0000-0003-1627-6848
Guillaume CazalsIBMMUMR5247, University of Montpellier, CNRS, ENSCM, Place Eugène Bataillon, 34095 Montpellier, France.
Véronique MartinezUMR Qualisud, University of Montpellier, 34095 Montpellier, France.
Caroline StrubUMR Qualisud, University of Montpellier, 34095 Montpellier, France.ORCID 0000-0001-9361-9715
Angélique FontanaUMR Qualisud, University of Montpellier, 34095 Montpellier, France.
Sabine Schorr-GalindoUMR Qualisud, University of Montpellier, 34095 Montpellier, France.ORCID 0000-0002-0484-2411
Université de Montpellier · FRCentre de Coopération Internationale en Recherche Agronomique pour le Développement · FRÉcole Nationale Supérieure de Chimie de Montpellier · FR

Funding

Agropolis Fondation 1605-052Conacyt 840486
6 · The paper itself

Abstract

Aflatoxin B

Indexed as

Aflatoxin B1Aspergillus flavusCarcinogensDecontaminationOchratoxinsPenicilliumStreptomycesAflatoxin B1Carcinogensochratoxin AOchratoxinsactinobacteriabiodegradationdetoxificationenzymesfungimycotoxins

Identifiers

PMID34066812
PMCPMC8151643
OpenAlexW3162579521

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.